September, which marks a transition from summer to fall with characteristics of both seasons in Northern Hemisphere countries like the U.S., is also a month of important observances such as World Alzheimer's Month, Blood Cancer Awareness Month, and Childhood Cancer Awareness Month, among others.
So, as we head into the final month of the third quarter, it's a good time to take a closer look at biotech and pharmaceutical companies with drug candidates awaiting FDA decisions. So far this year (January through August), the FDA has approved 25 novel drugs - slightly trailing the 29 approvals recorded during the same period last year.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com